OpenEvidence
Company Overview
OpenEvidence is the leading medical information platform, launched from the Mayo Clinic Platform Accelerate program. It aggregates, synthesizes, and visualizes clinically relevant medical evidence to support evidence-based decisions and improve patient outcomes.
Mission and Vision
Our mission is to organize and expand the world's collective medical knowledge. OpenEvidence addresses the extreme challenge of information overload in medicine by making medical research literature and clinical evidence accessible and understandable for healthcare professionals.
Industry Partnerships and Content Agreements
OpenEvidence has content agreements with prestigious organizations such as JAMA (The Journal of the American Medical Association) and The New England Journal of Medicine.
Team and Advisors
The team includes highly qualified individuals with backgrounds from Harvard, MIT, Princeton, and other reputable institutions. Medical advisors are affiliated with leading medical centers such as Cedars-Sinai, Mayo Clinic, Harvard Medical School, and others.
Investors
Investors supporting OpenEvidence include Sequoia Capital, Google Ventures, Kleiner Perkins, Breyer Capital, Conviction Partners, Mayo Clinic, and others.